INORGANIC NANOPARTICLES COMPOSITIONS IN COMBINATION WITH IONIZING RADIATIONS FOR TREATING CANCER
The present application relates to activable inorganic nanoparticles which can be used in the health sector, in particular in human health, to disturb, alter or destroy target cancerous cells, tissues or organs. It more particularly relates to nanoparticles which can generate a surprisingly efficient therapeutic effect, when concentrated inside the tumor and exposed to ionizing radiations. The invention also relates to pharmaceutical compositions comprising a population of nanoparticles as defined previously, as well as to their uses..
| Medienart: |
|
|---|
Patent| Erscheinungsjahr: |
2019 |
|---|---|
| Erschienen: |
2019 |
| Enthalten in: |
Europäisches Patentamt - (2019) vom: 10. Jan. Zur Gesamtaufnahme - year:2019 |
|---|
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
BORGHI ELSA [VerfasserIn] |
|---|
| Links: |
Volltext [kostenfrei] |
|---|
| Anmerkungen: |
Source: www.epo.org (no modifications made), First posted: 2019-01-10, Last update posted on www.tib.eu: 2024-04-17, Last updated: 2024-04-26 |
|---|
| Patentnummer: |
US2019008962 |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
EPA003411567 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | EPA003411567 | ||
| 003 | DE-627 | ||
| 005 | 20240426161451.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240415s2019 xx |||||o 00| ||eng c | ||
| 035 | |a (DE-627)EPA003411567 | ||
| 035 | |a (EPA)US2019008962 | ||
| 035 | |a (EPA)47710064 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 0 | |a BORGHI ELSA |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a INORGANIC NANOPARTICLES COMPOSITIONS IN COMBINATION WITH IONIZING RADIATIONS FOR TREATING CANCER |
| 264 | 1 | |c 2019 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Source: www.epo.org (no modifications made), First posted: 2019-01-10, Last update posted on www.tib.eu: 2024-04-17, Last updated: 2024-04-26 | ||
| 520 | |a The present application relates to activable inorganic nanoparticles which can be used in the health sector, in particular in human health, to disturb, alter or destroy target cancerous cells, tissues or organs. It more particularly relates to nanoparticles which can generate a surprisingly efficient therapeutic effect, when concentrated inside the tumor and exposed to ionizing radiations. The invention also relates to pharmaceutical compositions comprising a population of nanoparticles as defined previously, as well as to their uses. | ||
| 650 | 4 | |a A61K: Preparations for medical, dental, or toilet purposes (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms a61j0003000000;chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles a61l; soap compositions c11d) | |
| 650 | 4 | |a phy | |
| 650 | 4 | |a che | |
| 650 | 4 | |a med | |
| 650 | 4 | |a B82Y: Specific uses or applications of nanostructures; measurement or analysis of nanostructures; manufacture or treatment of nanostructures | |
| 650 | 4 | |a A61N: Electrotherapy; magnetotherapy; radiation therapy; ultrasound therapy (measurement of bioelectric currents a61b;surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body a61b0018000000;anaesthetic apparatus in general a61m;incandescent lamps h01k;infra-red radiators for heating h05b) | |
| 650 | 4 | |a 615 | |
| 700 | 0 | |a LEVY LAURENT |e verfasserin |4 aut | |
| 700 | 0 | |a POTTIER AGNES |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Europäisches Patentamt |g (2019) vom: 10. Jan. |
| 773 | 1 | 8 | |g year:2019 |g day:10 |g month:01 |
| 856 | 4 | 0 | |u https://worldwide.espacenet.com/patent/search/family/47710064/publication/US2019008962A1?q=US2019008962 |x 0 |z kostenfrei |3 Volltext |
| 912 | |a GBV_EPA | ||
| 951 | |a AR | ||
| 952 | |j 2019 |b 10 |c 01 | ||